Financials
ProAxsis secures c.£1.8mn investment | 15-Apr-2024 | 07:00 | RNS |
PDS Strategy Update and 2023 Financial Results | 27-Mar-2024 | 13:34 | RNS |
Business Update | 13-Mar-2024 | 07:00 | RNS |
Exercise of Options and Issue of Shares | 05-Feb-2024 | 07:00 | RNS |
Glycotest secures $1 million investment | 23-Jan-2024 | 07:00 | RNS |
DeepTech Recycling secures £1 million... | 01-Dec-2023 | 07:00 | RNS |
PDS BioTechnology: Third Quarter Results | 14-Nov-2023 | 16:39 | RNS |
Director/PDMR Shareholding | 13-Nov-2023 | 07:00 | RNS |
PDS Biotech Announces Updated Survival Data | 09-Nov-2023 | 17:28 | RNS |
Ventive secures c.£900,000 investment | 06-Nov-2023 | 07:00 | RNS |
Change of Adviser | 02-Nov-2023 | 07:00 | RNS |
Exercise of Options | 13-Oct-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 03-Oct-2023 | 16:12 | RNS |
PDS: Interim 24-month survival rate of 74% update | 03-Oct-2023 | 15:21 | RNS |
Interim Results | 28-Sep-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 63.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 80.50 |
52 Week Low | 49.00 |
Volume | 66,058 |
Shares Issued | 23.95m |
Market Cap | £15.09m |
RiskGrade | 410 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:29 | 29,948 @ 61.10p |
15:29 | 30,009 @ 61.00p |
14:31 | 3,101 @ 61.64p |
10:30 | 3,000 @ 62.89p |
CEO | Ilian Iliev |
CFO | Stephen Crowe |
You are here: research